tiprankstipranks
Advertisement
Advertisement

LVZPF Stock Latest News

Livzon Wins NMPA Nod for JP-1366 H. pylori Trial, Deepening GI Drug Portfolio
Company AnnouncementsLivzon Wins NMPA Nod for JP-1366 H. pylori Trial, Deepening GI Drug Portfolio
3d ago
Livzon Pharmaceutical Schedules Board Meeting to Review First-Quarter 2026 Results
PremiumCompany Announcements
Livzon Pharmaceutical Schedules Board Meeting to Review First-Quarter 2026 Results
5d ago
Livzon Clarifies 2025 Dividend Plan, Confirms RMB14.30 per 10 Shares
PremiumCompany Announcements
Livzon Clarifies 2025 Dividend Plan, Confirms RMB14.30 per 10 Shares
18d ago
Livzon Wins NMPA Nod to Trial Long-Acting Brexpiprazole for Schizophrenia
PremiumCompany Announcements
Livzon Wins NMPA Nod to Trial Long-Acting Brexpiprazole for Schizophrenia
18d ago
Livzon Pharmaceutical Strengthens Board Committees With New Appointments
PremiumCompany Announcements
Livzon Pharmaceutical Strengthens Board Committees With New Appointments
20d ago
Livzon Pharmaceutical Outlines Board and Committee Structure
PremiumCompany AnnouncementsLivzon Pharmaceutical Outlines Board and Committee Structure
20d ago
Livzon Pharmaceutical Proposes Final 2025 Dividend of RMB 14.3 per 10 Shares
Premium
Company Announcements
Livzon Pharmaceutical Proposes Final 2025 Dividend of RMB 14.3 per 10 Shares
20d ago
Livzon Pharmaceutical Publishes Audited 2025 Results and Annual Report
Premium
Company Announcements
Livzon Pharmaceutical Publishes Audited 2025 Results and Annual Report
20d ago
Livzon Pharmaceutical Cuts Registered Capital and Streamlines Board Structure
PremiumCompany Announcements
Livzon Pharmaceutical Cuts Registered Capital and Streamlines Board Structure
20d ago
LVZPF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
LVZPF Upcoming Earnings Report: What to Expect?
22d ago
Livzon Wins Vietnam Approval for Tender Offer for Imexpharm Shares
PremiumCompany Announcements
Livzon Wins Vietnam Approval for Tender Offer for Imexpharm Shares
1M ago
Livzon Pharmaceutical Sets March Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Livzon Pharmaceutical Sets March Board Meeting to Approve 2025 Annual Results
1M ago
Livzon Pharmaceutical Announces Senior Leadership Reshuffle and Board Changes
PremiumCompany AnnouncementsLivzon Pharmaceutical Announces Senior Leadership Reshuffle and Board Changes
1M ago
Livzon Pharmaceutical Group Details Board and Committee Structure
Premium
Company Announcements
Livzon Pharmaceutical Group Details Board and Committee Structure
1M ago
Livzon downgraded to Sell from Neutral at Goldman Sachs
Premium
The Fly
Livzon downgraded to Sell from Neutral at Goldman Sachs
2M ago
Livzon’s Psoriasis Biologic Lecankitug Enters China’s Priority Review Channel
PremiumCompany Announcements
Livzon’s Psoriasis Biologic Lecankitug Enters China’s Priority Review Channel
3M ago
Livzon Pharmaceutical Trims Stake in Fluffy Buddy Through Connected Deemed Disposal
PremiumCompany Announcements
Livzon Pharmaceutical Trims Stake in Fluffy Buddy Through Connected Deemed Disposal
3M ago
Livzon Extends Deadline and Launches Tender Offer Plan for Vietnam’s Imexpharm
PremiumCompany Announcements
Livzon Extends Deadline and Launches Tender Offer Plan for Vietnam’s Imexpharm
3M ago
Livzon Pharmaceutical Sets 2026 Caps on Connected Transactions With Livzon MAB
PremiumCompany Announcements
Livzon Pharmaceutical Sets 2026 Caps on Connected Transactions With Livzon MAB
3M ago
Livzon Sets 2026 Caps for Connected Transactions With Controlling Shareholder Joincare
PremiumCompany AnnouncementsLivzon Sets 2026 Caps for Connected Transactions With Controlling Shareholder Joincare
3M ago
Livzon’s Psoriasis Biologic Lecankitug Accepted for Review by China’s NMPA
Premium
Company Announcements
Livzon’s Psoriasis Biologic Lecankitug Accepted for Review by China’s NMPA
4M ago
Livzon Wins NMPA Nod to Test NS-041 Tablet for Depression in China
Premium
Company Announcements
Livzon Wins NMPA Nod to Test NS-041 Tablet for Depression in China
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >